Hyperthermia synergistically enhances antitumor efficacy of PARP inhibitor through impacting homologous recombination repair and oxidative stress in vitro

被引:2
|
作者
Wu, Qianqian [1 ,2 ]
Wei, Mingjing [1 ,2 ]
Yao, Lifang [1 ,2 ,5 ]
Cheng, Xiaodong [1 ,2 ,3 ]
Lu, Weiguo [1 ,2 ,3 ,4 ]
Xie, Xing [1 ,2 ,3 ]
Li, Xiao [1 ,2 ,3 ]
机构
[1] Zhejiang Univ, Womens Hosp, Sch Med, Dept Gynecol Oncol, Hangzhou 310006, Zhejiang, Peoples R China
[2] Zhejiang Univ, Womens Hosp, Sch Med, Zhejiang Prov Key Lab Precis Diag & Therapy Major, Hangzhou 310006, Zhejiang, Peoples R China
[3] Zhejiang Univ, Canc Ctr, Hangzhou 310058, Zhejiang, Peoples R China
[4] Ctr Uterine Canc Diag & Therapy Res Zhejiang Prov, Hangzhou 310006, Peoples R China
[5] Shaoxing Maternal & Child Hlth Hosp, Dept Obstet & Gynecol, Shaoxing 312000, Zhejiang, Peoples R China
关键词
Ovarian cancer; Hyperthermia; PARP inhibitor; Homologous recombination; Oxidative stress; CANCER-CELLS; MAINTENANCE THERAPY; BRCA2; DEGRADATION; OVARIAN-CANCER; DOUBLE-BLIND; DNA-REPAIR; POLY(ADP-RIBOSE); CHEMOTHERAPY; TUMORS;
D O I
10.1016/j.bbrc.2022.06.049
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumors with homologous recombination (HR) deficiency are particularly responsive to PARP inhibitors, however strategies to improve the sensitivity of epithelial ovarian carcinoma (EOC) with sufficient HR abilities still need to be deeply explored. In the present study, we firstly validated that hyperthermia (HT) changed diverse genes and signal pathways related to HR and oxidative stress in HR proficient EOC cells. HT impaired HR efficiency through inhibiting Olaparib (Olap) induced RAD51 foci formation in EOC cells, which was independent of the expression level of RAD51. Combination therapy of HT and Olap syner-gistically induced oxidative stress and oxidative DNA damage of EOC cells. Furthermore, we revealed that HT and Olap synergistically aggravated double-strand breaks of DNA in EOC cells. Conclusively, our findings confirmed that HT could synergistically enhance HR proficient EOC cells' sensitivity to PARP inhibitor through impairing HR efficiency and increasing oxidative stress. (c) 2022 Published by Elsevier Inc.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 8 条
  • [1] GPX4 Inhibition Enhances the Antitumor Effect of PARP Inhibitor on Homologous Recombination Proficient Ovarian Cancer Cells
    Gu, Jiaxin
    Qian, Senmi
    Qian, Fangfang
    Wu, Xiaodong
    Chen, Lifeng
    Chen, Xiaojing
    Chen, Zhuoye
    Song, Feifei
    Zheng, Mengxia
    Wang, Lingfang
    Cheng, Xiaodong
    CURRENT CANCER DRUG TARGETS, 2024,
  • [2] PARP inhibitor boost the efficacy of photothermal therapy to TNBC through enhanced DNA damage and inhibited homologous recombination repair
    Li, Yang
    Miao, Wenfang
    Yuan, Chen
    Tang, Jiajia
    Zhong, Nan
    Jin, Yingying
    Hu, Yongzhi
    Tang, Yuxia
    Wang, Shouju
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2025, 15 (03) : 955 - 967
  • [3] A novel UCHL3 inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair
    Song, Zhiwang
    Tu, Xinyi
    Zhou, Qin
    Huang, Jinzhou
    Chen, Yuping
    Liu, Jiaqi
    Lee, SeungBaek
    Kim, Wootae
    Nowsheen, Somaira
    Luo, Kuntian
    Yuan, Jian
    Lou, Zhenkun
    CELL DEATH & DISEASE, 2019, 10 (6)
  • [4] LRRK2 inhibition potentiates PARP inhibitor cytotoxicity through inhibiting homologous recombination-mediated DNA double strand break repair
    Chen, Lifeng
    Hou, Jing
    Zeng, Xiangyu
    Guo, Qiang
    Deng, Min
    Kloeber, Jake A.
    Tu, Xinyi
    Zhao, Fei
    Wu, Zheming
    Huang, Jinzhou
    Luo, Kuntian
    Kim, Wootae
    Lou, Zhenkun
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (03):
  • [5] Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer
    Mansour, W. Y.
    Tennstedt, P.
    Volquardsen, J.
    Oing, C.
    Kluth, M.
    Hube-Magg, C.
    Borgmann, K.
    Simon, R.
    Petersen, C.
    Dikomey, E.
    Rothkamm, K.
    SCIENTIFIC REPORTS, 2018, 8
  • [6] FL118 Enhances Therapeutic Efficacy in Colorectal Cancer by Inhibiting the Homologous Recombination Repair Pathway through Survivin-RAD51 Downregulation
    Kim, Jungyoun
    Jeong, Yeyeong
    Shin, You Me
    Kim, Sung Eun
    Shin, Sang Joon
    CANCERS, 2024, 16 (19)
  • [7] Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells
    Chen, Xi
    Zhu, Ning
    Wu, Yajie
    Zhang, Ye
    Zhang, Yuxuan
    Jin, Kaiwen
    Zhou, Zhiyi
    Chen, Guang
    Wang, Jiabing
    PHYTOMEDICINE, 2024, 128
  • [8] Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APEI repair and redox activity in non-small-cell lung cancer
    Ren, Tao
    Shan, Jinlu
    Li, Mengxia
    Qing, Yi
    Qian, Chengyuan
    Wang, Guangjie
    Li, Qing
    Lu, Guoshou
    Li, Chongyi
    Peng, Yu
    Luo, Hao
    Zhang, Shiheng
    Yang, Yuxing
    Cheng, Yi
    Wang, Dong
    Zhou, Shu-Feng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2887 - 2910